LA JOLLA, CA, April 30, 2024 – Enlaza Therapeutics, the first covalent biologic platform company, today announced a $100 million Series A financing. The financing will be used to further...
Eric will join a panel discussion on the challenges facing personalized medicine at a featured Personalized Medicine Coalition event at the North Carolina Biotechnology Center on November 16.
News | 11. 03. 2011
Eric will join a panel discussion on the challenges facing personalized medicine at a featured Personalized Medicine Coalition event at the North Carolina Biotechnology Center on November 16.
© 2024 Pappas Capital, LLC. ALL RIGHTS RESERVED.